MiR-30a overexpression in lung tumor culture cells inhibits migration and cell invasion, and partially attributes to lower EYA2 expression [64] and influences NSCLC progression through the PI3K/AKT signaling pathway by targeting IGF1R [65]. The gene discussed is EYA2; the disease is non-small cell lung carcinoma.